A-Z
Latest

Coeliac disease overview

history control tooltip

divider handle tooltip

These are the paths in the Coeliac disease pathway:

Coeliac disease HAI

About

What is covered

This pathway covers the recognition and assessment of coeliac disease in adults and children.
Coeliac disease is an autoimmune disorder that involves a heightened immunological response to ingested gluten in genetically susceptible people. It was believed to be uncommon but population-based studies show that it is much more prevalent than previously thought.
Although people with coeliac disease often have gastrointestinal symptoms, other symptoms are increasingly being recognised and some people have no symptoms at all.
Coeliac disease often coexists with other conditions.

Updates

Updates to this pathway

22 July 2014 Link added to constipation pathway
20 March 2014 Minor maintenance update
2 January 2014 Minor maintenance update
31 May 2013 Minor maintenance update
23 October 2012 Minor maintenance update

Patient-centred care

Patients and healthcare professionals have rights and responsibilities as set out in the NHS Constitution for England – all NICE guidance is written to reflect these. Treatment and care should take into account individual needs and preferences. People should have the opportunity to make informed decisions about their care and treatment, in partnership with their healthcare professionals. If the person is under 16, their family or carers should also be given information and support to help the child or young person to make decisions about their treatment. Healthcare professionals should follow the Department of Health's advice on consent. If someone does not have capacity to make decisions, healthcare professionals should follow the code of practice that accompanies the Mental Capacity Act and the supplementary code of practice on deprivation of liberty safeguards.
For young people moving between paediatric and adult services, care should be planned and managed according to the best practice guidance described in the Department of Health’s Transition: getting it right for young people.
Adult and paediatric healthcare teams should work jointly to provide assessment and services to young people. Diagnosis and management should be reviewed throughout the transition process, and there should be clarity about who is the lead clinician to ensure continuity of care.

Short Text

Recognition and assessment of coeliac disease.

What is covered

This pathway covers the recognition and assessment of coeliac disease in adults and children.
Coeliac disease is an autoimmune disorder that involves a heightened immunological response to ingested gluten in genetically susceptible people. It was believed to be uncommon but population-based studies show that it is much more prevalent than previously thought.
Although people with coeliac disease often have gastrointestinal symptoms, other symptoms are increasingly being recognised and some people have no symptoms at all.
Coeliac disease often coexists with other conditions.

Updates

Updates to this pathway

22 July 2014 Link added to constipation pathway
20 March 2014 Minor maintenance update
2 January 2014 Minor maintenance update
31 May 2013 Minor maintenance update
23 October 2012 Minor maintenance update

Sources

NICE guidance

The NICE guidance that was used to create the pathway.
Coeliac disease. NICE clinical guideline 86 (2009)

Quality standards

Quality statements

Effective interventions library

Effective interventions library

Successful effective interventions library details

Implementation

Commissioning

These resources include support for commissioners to plan for costs and savings of guidance implementation and meeting quality standards where they apply.
These resources will help to inform discussions with providers about the development of services and may include measurement and action planning tools.

Education and learning

NICE produces resources for individual practitioners, teams and those with a role in education to help improve and assess users' knowledge of relevant NICE guidance and its application in practice.

Service improvement and audit

These resources provide help with planning ahead for NICE guidance, understanding where you are now, and conducting improvement initiatives.

Information for the public

NICE produces information for the public that summarises, in plain English, the recommendations that NICE makes to healthcare and other professionals.
NICE has written information for the public explaining its guidance on each of the following topics.

Pathway information

Patient-centred care

Patients and healthcare professionals have rights and responsibilities as set out in the NHS Constitution for England – all NICE guidance is written to reflect these. Treatment and care should take into account individual needs and preferences. People should have the opportunity to make informed decisions about their care and treatment, in partnership with their healthcare professionals. If the person is under 16, their family or carers should also be given information and support to help the child or young person to make decisions about their treatment. Healthcare professionals should follow the Department of Health's advice on consent. If someone does not have capacity to make decisions, healthcare professionals should follow the code of practice that accompanies the Mental Capacity Act and the supplementary code of practice on deprivation of liberty safeguards.
For young people moving between paediatric and adult services, care should be planned and managed according to the best practice guidance described in the Department of Health’s Transition: getting it right for young people.
Adult and paediatric healthcare teams should work jointly to provide assessment and services to young people. Diagnosis and management should be reviewed throughout the transition process, and there should be clarity about who is the lead clinician to ensure continuity of care.

Supporting information

Glossary

Anti-gliadin antibodies
Anti-endomysial antibodies
Human leukocyte antigen DQ2/DQ8
Immunoglobulin A
Immunoglobulin G
Anti-tissue transglutaminase antibodies

Paths in this pathway

Pathway created: October 2012 Last updated: May 2014

Copyright © 2014 National Institute for Health and Care Excellence. All Rights Reserved.

Recently viewed